Clal Biotechnology Industries Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Clal Biotechnology Industries Limited with three other
miscellaneous service companies in Middle East:
sales of 1.70 million Israel Shekels [US$477,299.81 ]
Redhill Biopharma Ltd
(386,233.09 Israel Shekels [US$108,249.55 ]
(25.01 million Israel Shekels [US$7.01 million]
of which 100%
was Agricultural Crops).
Clal Biotechnology Industries Limited reported sales of 25.01 million Israel Shekels (US$7.01 million)
December of 2016.
decrease of 21.3%
versus 2015, when the company's sales were 31.77 million Israel Shekels.
Contributing to the drop in overall sales was the 80.4% decline
in Gmida Sal, from 18.62 million Israel Shekels to 3.65 million Israel Shekels.
There were also decreases in sales in
Kayortech (down 25.6% to 16.89 million Israel Shekels)
Other (down 79.5% to 6.11 million Israel Shekels)
However, these declines were partially offset by the increase in sales of
Medivned (up 86.9% to 14.79 million Israel Shekels)